Ying Jiang

Ophthalmology

1 Essex Center Dr
Peabody, MA 01960

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).

Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).

Journal: The Lancet. Respiratory medicine

Published: October 15, 2014

Showing 1-1 of 1

Last Updated: 09/26/2026